SynthesisClinical and experimental medicine2023

Lower risk of hepatocellular carcinoma with tenofovir than entecavir in antiviral treatment-naïve chronic hepatitis B patients: a systematic review and meta-analysis involving 90,897 participants.

Jinman Shao et al.PubMed ↗Publisher ↗

No numbers read from the abstract.